EJ, A., M, W., BJ, S., A, C., A, B., E, E., & DJ, H. (2018). Direct comparison of the abilities of bone marrow mesenchymal versus hematopoietic stem cells to reverse hyperglycemia in diabetic NOD.SCID mice. Islets, 10(4), 137. https://doi.org/10.1080/19382014.2018.1480285
Chicago Style (17th ed.) CitationEJ, Arany, Waseem M, Strutt BJ, Chamson-Reig A, Bernardo A, Eng E, and Hill DJ. "Direct Comparison of the Abilities of Bone Marrow Mesenchymal Versus Hematopoietic Stem Cells to Reverse Hyperglycemia in Diabetic NOD.SCID Mice." Islets 10, no. 4 (2018): 137. https://doi.org/10.1080/19382014.2018.1480285.
MLA (9th ed.) CitationEJ, Arany, et al. "Direct Comparison of the Abilities of Bone Marrow Mesenchymal Versus Hematopoietic Stem Cells to Reverse Hyperglycemia in Diabetic NOD.SCID Mice." Islets, vol. 10, no. 4, 2018, p. 137, https://doi.org/10.1080/19382014.2018.1480285.